Updated Jul 16, 2026
Johnson David Michael has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Johnson David Michael is an individual associated with Aura Biosciences, Inc. according to SEC filings dated 2026-06-15. The available context does not specify his exact role (e.g., officer, director, or beneficial owner) at the company. Aura Biosciences is a publicly traded biotechnology company; public details about Mr. Michael's background, tenure, and career are not provided in the provided SEC context. No definitive information confirms other affiliations or achievements beyond the Aura Biosciences filing context.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | ZNTL | Zentalis Pharmaceuticals, Inc. | A — Grant or award | 57.1K | $0.00 | |
| 2026-06-15 | AURA | Aura Biosciences, Inc. | A — Grant or award | 15.0K | $0.00 |
Johnson David Michael is an individual associated with Aura Biosciences, Inc. according to SEC filings dated 2026-06-15. The available context does not specify his exact role (e.g., officer, director, or beneficial owner) at the company. Aura Biosciences is a publicly traded biotechnology company; public details about Mr. Michael's background, tenure, and career are not provide…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Johnson David Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.